Children's Hospital Boston
When certain blood cancers recur after an initial treatment, they can be highly resistant to new bouts of chemotherapy and radiation. But researchers in Boston believe they've come up with a new synthetic anti-cancer peptide that helps overcome this.
Boston-based researchers may have figured out how to develop and use "smart" nanotherapeutics to treat patients with Type 1 diabetes. In their in vitro work, scientists from Children's...